Promoter debt refinancing cuts pledged Thyrocare stake to 61%
THYROCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.0 pts less than Nifty Microcap 250 and 1.7 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
API Holdings plans to borrow up to Rs 1,700 crore through secured, unlisted debt that cannot be converted into shares, to fully redeem its existing debentures. These have a redemption value of Rs 1,820 crore and an outstanding nominal value of Rs 1,545.38 crore. Docon's pledge over all 71.06% of Thyrocare shares will be replaced by a pledge of up to 61%.
Control is unchanged now, but enforcement of the new pledge could affect it. The pledged promoter stake would fall from 71.06% to at most 61%.